Latin America's Digital Therapeutics Market Surges Amid Healthcare Evolution
São Paulo, Monday, 10 November 2025.
The digital therapeutics market in Latin America is expanding due to rising chronic disease rates and initiatives for digital health integration, led by companies like Welldoc and Omada Health.
Market Drivers and Growth
The expansion of the digital therapeutics market in Latin America is primarily driven by the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases. These health challenges necessitate innovative solutions, leading to a surge in digital health initiatives. Major stakeholders, including government bodies and private companies, are actively promoting digital integration within traditional healthcare frameworks to enhance patient outcomes and streamline operations [1].
Regulatory and Infrastructure Developments
In November 2025, the Pan American Health Organization introduced a unified regulatory framework for digital therapeutics, significantly influencing market dynamics by easing entry barriers and standardizing practices across the region [1]. This regulatory advancement is complemented by infrastructure improvements, such as Brazil’s integration of digital therapeutic platforms for managing diabetes, hypertension, and mental health within its public healthcare system, impacting 25 million patients [1].
Technological and Financial Support
Technological advancements and financial investments are further propelling the market. Notably, venture capital funding for digital health startups in Latin America reached USD 850 million in the third quarter of 2025, with 65% directed towards therapeutic applications [1]. This financial influx supports the development and deployment of advanced digital solutions, fostering a robust ecosystem for healthcare innovation.
Regional Collaborations and Market Expansion
Collaborations between technology firms and healthcare providers are essential to market growth. In Argentina, partnerships between mobile network operators and digital therapeutics providers have led to a substantial increase in user engagement by facilitating zero-rated data access for health applications [1]. These strategic alliances enhance the accessibility and effectiveness of digital health solutions, driving the market’s expansion across the region.